ROCKLAND, Mass.--(BUSINESS WIRE)--BioSphere Medical, Inc. (NASDAQ: BSMD), a medical device company that pioneered the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a procedure called embolization, announced today that Richard Faleschini, President and Chief Executive Officer, is scheduled to present at Rodman & Renshaw’s 8th Annual Healthcare Conference on Monday, November 6, 2006 at 12:25 PM Eastern Time. The conference is being held at The New York Palace Hotel.
